Evommune EVMN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.99M-920% | $852.32K+229% | $259K— | —— | -$126.78K+54.4% | ||
| $4.58K-2.7% | $4.71K— | —— | —— | $6.23K-20.1% | ||
| $123.29K— | —— | —— | —— | $252.91K+144% | ||
| —— | —— | —— | —— | -$1.97K+75.8% | ||
| -$145.76K-134% | $429.26K— | —— | —— | -$5.84K-123% | ||
| $42.04K+142% | -$100.26K— | —— | —— | $111.14K+35,956% | ||
| $91.42K+109% | -$1.07M— | —— | —— | $86.96K+163% | ||
| -$37.9K-111% | $348.93K— | —— | —— | -$17.03K+34.3% | ||
| -$11.15K-251% | $7.4K— | —— | —— | -$7.07K-414% | ||
| $69.29K— | —— | —— | —— | —— | ||
| $11.53K0.0% | $11.53K— | —— | —— | $11.53K0.0% | ||
| $87.88K+2.3% | $85.89K— | —— | —— | $80.36K+1.7% | ||
| $6.9M— | —— | —— | —— | —— | ||
| -$90.99K-6.6% | -$85.31K— | —— | —— | -$79.5K-68.2% | ||
| $77.05K— | —— | —— | —— | —— | ||
| -$424.56K+84.6% | -$2.75M— | —— | —— | $175.99K+213% | ||
| $150.6K-49.6% | $298.86K0.0% | $298.86K0.0% | $298.86K0.0% | $298.86K— | ||
| —— | $24.93K0.0% | $24.93K0.0% | $24.93K-49.1% | $48.95K-47.9% | ||
| $897+4.4% | $859— | —— | —— | $894+6.0% | ||
| $123.29K+399% | $24.71K+209% | $8K-96.9% | $257.45K+1.8% | $252.9K— | ||
| $616.03K+1,266% | $45.08K0.0% | $45.08K0.0% | $45.08K0.0% | $45.08K— | ||
| —— | $2M0.0% | $2M0.0% | $2M0.0% | $2M— | ||
| -$1.22M-127% | $4.47M— | —— | —— | -$174K-83.8% | ||
| -$1.65M-196% | $1.72M— | —— | —— | $1.99K+105% | ||
| $19.47K-87.8% | $159.75K— | —— | —— | $71.98K+92.5% | ||
| —— | $40.96K— | —— | —— | $18.46K+620% | ||
| $11.53K0.0% | $11.53K— | —— | —— | $11.53K0.0% | ||
| $4.58K-2.7% | $4.71K-4.7% | $4.94K— | —— | —— | ||
| $25.37K-98.6% | $1.84M0.0% | $1.84M0.0% | $1.84M0.0% | $1.84M— | ||
| -$78.43K— | —— | —— | —— | —— | ||
| —— | $150— | —— | —— | $23.14K— | ||
| $78.43K— | —— | —— | —— | —— | ||
| $206.46K+111% | -$1.84M0.0% | -$1.84M0.0% | -$1.84M0.0% | -$1.84M— | ||
| $77.05K— | —— | —— | —— | —— | ||
| -$90.99K-6.6% | -$85.31K— | —— | —— | -$79.5K-68.2% | ||
| -$11.15K-251% | $7.4K— | —— | —— | -$7.07K-414% | ||
| -$37.9K-111% | $348.93K— | —— | —— | -$17.03K+34.3% | ||
| —— | $30.58K0.0% | $30.58K0.0% | $30.58K0.0% | $30.58K— | ||
| —— | $20.13K0.0% | $20.13K0.0% | $20.13K0.0% | $20.13K— | ||
| $6.31M+377% | $1.32M0.0% | $1.32M0.0% | $1.32M0.0% | $1.32M— | ||
| -$6.99M— | —— | —— | —— | -$126.78K— | ||
| $87.88K+2.3% | $85.89K— | —— | —— | $80.36K+1.7% | ||
| —— | —— | —— | —— | -$1.97K+75.8% | ||
| $206.46K-88.8% | $1.84M0.0% | $1.84M0.0% | $1.84M0.0% | $1.84M— | ||
| $450K— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $45K— | ||
| $616.03K+1,266% | $45.08K0.0% | $45.08K0.0% | $45.08K0.0% | $45.08K— | ||
| —— | $1.05M— | —— | —— | $127.78K+89.3% | ||
| —— | $8M— | —— | —— | —— | ||
| $450K— | —— | —— | —— | —— | ||
| $149.14K-57.1% | $347.62K— | —— | —— | $1.69K-30.9% | ||
| —— | $0.090.0% | $0.090.0% | $0.090.0% | $0.09— | ||
| —— | $0.100.0% | $0.100.0% | $0.100.0% | $0.10— | ||
| $5.11K+17,681% | $28.750.0% | $28.750.0% | $28.750.0% | $28.75— | ||
| $684.39K-16.9% | $823.77K+15.1% | $715.82K-17.2% | $864.44K+19.5% | $723.49K+4.8% | ||
| —— | $3.32M0.0% | $3.32M0.0% | $3.32M0.0% | $3.32M— | ||
| -$0.36-500% | $0.09+125% | $0.04— | —— | -$0.02+50.0% | ||
| -$0.36-1,900% | $0.02-50.0% | $0.04— | —— | -$0.02+50.0% | ||
| $1.38M-15.5% | $1.63M+74.2% | $937.76K-2.2% | $958.49K+33.1% | $720.23K-28.2% | ||
| $961.13K+43.3% | $670.76K-31.4% | $978.35K+1.1% | $968.1K+11.7% | $866.76K-12.4% | ||
| $25.8K-68.1% | $80.98K-47.9% | $155.31K+119% | $71.01K-25.3% | $95.09K-33.2% | ||
| $2.91K-96.0% | $73.21K+9,074% | $798+103% | $393+31.4% | $299+6.4% | ||
| -$682.81K+39.7% | -$1.13M-1,347% | -$78.29K+49.6% | -$155.44K-384% | -$32.1K+76.4% | ||
| 96%+3.0% | 93%— | —— | —— | 93%0.0% | ||
| 100%— | —— | —— | —— | —— | ||
| $1.65M+10.1% | $1.49M-11.8% | $1.69M-7.6% | $1.83M+15.2% | $1.59M-5.3% | ||
| $263.71K+55.2% | $169.87K+42.9% | $118.88K-28.0% | $165.04K-7.6% | $178.63K+46.9% | ||
| —— | 85.1M— | —— | —— | —— | ||
| 19.6M-77.0% | 85.1M+1,083% | 7.2M— | 0-100% | 6.9M+3.3% | ||
| 19.6M+138% | 8.2M+17.1% | 7M— | —— | 6.9M+3.3% | ||
| —— | $150— | —— | —— | $23.14K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Evommune generate?
- Evommune (EVMN) generated -$2.9M in operating cash flow over the trailing twelve months.
- Where does Evommune 's cash flow data come from?
- Every line is extracted from Evommune 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
